Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
IQVIA
IQV
$40.1B
| $110M | 0.09% |
737,547
-93,600
| -11% | -$14.6M |
|
252
Ionis Pharmaceuticals
IONS
$9.21B
| $109M | 0.09% |
1,813,011
+57,700
| +3% | +$3.76M |
|
|
PCH
253
DELISTED
PotlatchDeltic
PCH
| $108M | 0.09% |
2,636,713
+29,800
| +1% | +$1.16M |
|
254
Outfront Media
OUT
$5.27B
| $108M | 0.09% |
3,948,252
+289,756
| +8% | +$7.72M |
|
255
Allstate
ALL
$66.3B
| $107M | 0.09% |
988,100
-258,600
| -21% | -$27M |
|
256
Darden Restaurants
DRI
$24.9B
| $107M | 0.09% |
906,892
+673,000
| +288% | +$82.1M |
|
|
VRE
257
DELISTED
Veris Residential
VRE
| $107M | 0.09% |
4,945,325
-67,175
| -1% | -$1.49M |
|
258
Lam Research
LRCX
$390B
| $107M | 0.09% |
4,627,560
-93,150
| -2% | -$1.96M |
|
259
Constellation Brands
STZ
$22.9B
| $107M | 0.09% |
515,100
+473,700
| +1,144% | +$95.1M |
|
260
Tenaris
TS
$27B
| $107M | 0.09% |
5,040,000
+3,615,100
| +254% | +$84.7M |
|
261
Black Hills Corp
BKH
$5.59B
| $107M | 0.09% |
1,389,915
+156,815
| +13% | +$12.2M |
|
262
UBS Group
UBS
$176B
| $106M | 0.09% |
9,354,500
+4,393,900
| +89% | +$49.5M |
|
263
Morgan Stanley
MS
$338B
| $105M | 0.09% |
2,471,200
+1,117,100
| +82% | +$47.7M |
|
264
Alliant Energy
LNT
$17.8B
| $105M | 0.09% |
1,941,804
-84,200
| -4% | -$4.32M |
|
265
MKS Inc
MKSI
$19.9B
| $105M | 0.09% |
1,133,869
-463,883
| -29% | -$38.3M |
|
|
AVP
266
DELISTED
Avon Products, Inc.
AVP
| $104M | 0.09% |
23,672,978
-1,060,800
| -4% | -$4.48M |
|
267
Crocs
CROX
$6.31B
| $104M | 0.09% |
3,749,900
-105,400
| -3% | -$2.55M |
|
268
Sabesp
SBS
$17.7B
| $104M | 0.09% |
45,155,384
+7,067,014
| +19% | +$17.8M |
|
|
PINC
269
DELISTED
Premier
PINC
| $103M | 0.09% |
3,572,609
+406,300
| +13% | +$15.1M |
|
270
WSFS Financial
WSFS
$4.14B
| $103M | 0.09% |
2,332,833
-40,500
| -2% | -$1.7M |
|
271
Avista
AVA
$3.22B
| $103M | 0.09% |
2,121,218
+330,788
| +18% | +$15.4M |
|
|
ZAYO
272
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $102M | 0.09% |
+3,020,000
| New | +$102M |
|
|
ZNGA
273
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $102M | 0.09% |
17,578,293
-1,833,507
| -9% | -$11M |
|
|
HTZ
274
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $101M | 0.09% |
7,327,808
+685,000
| +10% | +$9.65M |
|
275
Kinder Morgan
KMI
$70.1B
| $101M | 0.09% |
4,915,200
-7,930,500
| -62% | -$163M |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.